Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Science ; 350(6263): 985-90, 2015 Nov 20.
Article in English | MEDLINE | ID: mdl-26494174

ABSTRACT

The immune system plays an important role in regulating tumor growth and metastasis. Classical monocytes promote tumorigenesis and cancer metastasis, but how nonclassical "patrolling" monocytes (PMo) interact with tumors is unknown. Here we show that PMo are enriched in the microvasculature of the lung and reduce tumor metastasis to lung in multiple mouse metastatic tumor models. Nr4a1-deficient mice, which specifically lack PMo, showed increased lung metastasis in vivo. Transfer of Nr4a1-proficient PMo into Nr4a1-deficient mice prevented tumor invasion in the lung. PMo established early interactions with metastasizing tumor cells, scavenged tumor material from the lung vasculature, and promoted natural killer cell recruitment and activation. Thus, PMo contribute to cancer immunosurveillance and may be targets for cancer immunotherapy.


Subject(s)
Immunologic Surveillance/immunology , Lung Neoplasms/immunology , Lung Neoplasms/secondary , Monocytes/immunology , Animals , Immunotherapy/methods , Killer Cells, Natural/immunology , Lung Neoplasms/therapy , Mice , Mice, Mutant Strains , Neoplasm Invasiveness , Neoplasm Metastasis , Neoplasms, Experimental/immunology , Neoplasms, Experimental/secondary , Nuclear Receptor Subfamily 4, Group A, Member 1/genetics
2.
Circ Res ; 110(3): 416-27, 2012 Feb 03.
Article in English | MEDLINE | ID: mdl-22194622

ABSTRACT

RATIONALE: NR4A1 (Nur77) is a nuclear receptor that is expressed in macrophages and within atherosclerotic lesions, yet its function in atherosclerosis is unknown. OBJECTIVE: Nur77 regulates the development of monocytes, particularly patrolling Ly6C(-) monocytes that may be involved in resolution of inflammation. We sought to determine how absence of nuclear receptor subfamily 4, group A, member 1 (NR4A1) in hematopoietic cells affected atherosclerosis development. METHODS AND RESULTS: Nur77(-/-) chimeric mice on a Ldlr(-/-) background showed a 3-fold increase in atherosclerosis development when fed a Western diet for 20 weeks, despite having a drastic reduction in Ly6C(-) patrolling monocytes. In a second model, mice deficient in both Nur77 and ApoE (ApoE(-/-)Nur77(-/-)) also showed increased atherosclerosis after 11 weeks of Western diet. Atherosclerosis was associated with a significant change in macrophage polarization toward a proinflammatory phenotype, with high expression of tumor necrosis factor-α and nitric oxide and low expression of Arginase-I. Moreover, we found increased expression of toll-like receptor 4 mRNA and protein in Nur77(-/-) macrophages as well as increased phosphorylation of the p65 subunit of NFκB. Inhibition of NFκB activity blocked excess activation of Nur77(-/-) macrophages. CONCLUSIONS: We conclude that the absence of Nur77 in monocytes and macrophages results in enhanced toll-like receptor signaling and polarization of macrophages toward a proinflammatory M1 phenotype. Despite having fewer monocytes, Nur77(-/-) mice developed significant atherosclerosis when fed a Western diet. These studies indicate that Nur77 is a novel target for modulating the inflammatory phenotype of monocytes and macrophages and may be important for regulation of atherogenesis.


Subject(s)
Atherosclerosis/pathology , Gene Deletion , Inflammation/pathology , Macrophages/pathology , Nuclear Receptor Subfamily 4, Group A, Member 1/deficiency , Phenotype , Animals , Apolipoproteins E/deficiency , Apolipoproteins E/genetics , Apolipoproteins E/physiology , Atherosclerosis/etiology , Atherosclerosis/physiopathology , Diet/adverse effects , Disease Models, Animal , Humans , Inflammation/physiopathology , Lipid Metabolism/physiology , Macrophages/physiology , Mice , Mice, Inbred C57BL , Mice, Knockout , NF-kappa B/physiology , Nuclear Receptor Subfamily 4, Group A, Member 1/genetics , Nuclear Receptor Subfamily 4, Group A, Member 1/physiology , Receptors, LDL/deficiency , Receptors, LDL/genetics , Receptors, LDL/physiology , Toll-Like Receptors/physiology
SELECTION OF CITATIONS
SEARCH DETAIL
...